Refractory Sclerosing Mesenteritis/Mesenteric Panniculitis Presenting With Macrophage Activation Syndrome Treated With Rituximab

REFERENCES

1. 1.↵
   1. Nyberg L,
   2. Björk J,
   3. Björkdahl P,
   4. Ekberg O,
   5. Sjöberg K,
   6. Vigren L.

   Sclerosing mesenteritis and mesenteric panniculitis – clinical experience and radiological features. BMC Gastroenterol 2017;17:75.

   OpenUrlPubMed
2. 2.↵
   1. Fujita Y,
   2. Matsumoto H,
   3. Asano T, et al

   . Hemophagocytic lymphohistiocytosis associated with disseminated nontuberculous mycobacterial infection in a patient with mesenteric panniculitis. Tohoku J Exp Med 2021;253:151-7.

   OpenUrlPubMed
3. 3.↵
   1. Sulbaran M,
   2. Chen FK,
   3. Farraye FA,
   4. Hashash JG.

   A clinical review of mesenteric panniculitis. Gastroenterol Hepatol 2023;19:211-8.

   OpenUrl
4. 4.↵
   1. Généreau T,
   2. Bellin MF,
   3. Wechsler B, et al

   . Demonstration of efficacy of combining corticosteroids and colchicine in two patients with idiopathic sclerosing mesenteritis. Dig Dis Sci 1996;41:684-8.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Alsuhaimi MA,
   2. Alshowaiey RA,
   3. Alsumaihi AS,
   4. Aldhafeeri SM.

   Mesenteric panniculitis various presentations and management: a single institute ten years, experience. Ann Med Surg 2022;80:104203.

   OpenUrl
6. 6.↵
   1. Danford CJ,
   2. Lin SC,
   3. Wolf JL.

   Sclerosing mesenteritis. Am J Gastroenterol 2019;114:867-73.

   OpenUrlPubMed